According to Organovo's latest financial reports the company's current earnings (TTM) are -$19.09 M. In 2022 the company made an earning of -$11.71 M an increase over its 2021 earnings that were of -$12.14 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$19.09 M | 62.98% |
2022 | -$11.71 M | -3.48% |
2021 | -$12.14 M | -28.43% |
2020 | -$16.96 M | -26.2% |
2019 | -$22.97 M | -15.23% |
2018 | -$27.1 M | -28.72% |
2017 | -$38.02 M | 5.18% |
2016 | -$36.14 M | -4.89% |
2015 | -$38 M | 32.09% |
2014 | -$28.77 M | -18.93% |
2013 | -$35.49 M | -18.53% |
2012 | -$43.56 M | 27253.89% |
2011 | -$0.16 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
General Electric GE | $11.30 B | -59,362.17% | ๐บ๐ธ USA |
3M MMM | -$9.69 B | 50,667.70% | ๐บ๐ธ USA |
Intuitive Surgical ISRG | $1.76 B | -9,358.50% | ๐บ๐ธ USA |
United Therapeutics UTHR | $1.33 B | -7,088.42% | ๐บ๐ธ USA |
Stratasys SSYS | -$87.58 M | 358.94% | ๐ฎ๐ฑ Israel |
3D Systems DDD | -$95.4 M | 399.90% | ๐บ๐ธ USA |